Birgit Keil
14Patents
3h-index
54Co-inventors
59Inventor score
Filing activity: Sep 22, 2006 → Nov 10, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8466280B2 | Co-crystal compound of rivaroxaban and malonic acid | Human Necessities | 10 | Active |
| US9340535B2 | N-[5-(Aminosulfony1)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide mesylate monohydrate | Human Necessities | 5 | Active |
| US9637459B2 | Sodium and calcium salts of dihydroquinazoline derivative and use thereof as antiviral agents | Chemistry; Metallurgy | 3 | Active |
| US9957232B2 | 4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate | Chemistry; Metallurgy | 2 | Active |
| US8188270B2 | Polymorphous form of 5-chloro-N-({(5S)-2-oxo-3[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide | Human Necessities | 2 | Active |
| US10316001B2 | Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrohydro pyrimidine-5-carbonitrile | Chemistry; Metallurgy | 1 | Active |
| US9926305B2 | Salts | Human Necessities | 1 | Active |
| US10087183B2 | Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1h-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate | Human Necessities | 1 | Active |
| US10662188B2 | Forms of methyl {4,6-diamino-2-[1 (2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl} methyl carbamate | Human Necessities | 0 | Active |
| US11203593B2 | Forms of methyl {4,6-diamino-2-[1(2-fluorobenzyl)-1H-pyrazolo[3-4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate | Human Necessities | 0 | Active |
| US12202805B2 | Process for preparing (5S)-{[2-(4-carboxyphenyl)ethyl] |2-(2-{|3-chloro-4'-(trifluoromethyl)biphenyl-4-yl]methoxy}phenyl)ethyl]aminol-5,6,7,8-tetrahydroquinoline-2-carboxylic acid and its crystalline forms for use as pharmaceutically active compound | Human Necessities | 0 | Active |
| US12138256B2 | Treatment of cardiopulmonary disorders | Human Necessities | 0 | Active |
| US10336716B2 | Thermodynamically stable crystal modification of 2-methyl-N-(5-methyl-1, 3, 4-oxadiazol-2-yl)-3-(methylsulfonyl)-4-(trifluoromethyl)benzamide | Chemistry; Metallurgy | 0 | Active |
| US10676443B2 | Method for producing (4S)-4-[4-cyano-2-(methylsulfonyl)phenyl]-3,6-dimethyl-2-oxo-1-[3-(trifluoromethyl)phenyl]-1,2,3,4-tetrahydro pyrimidine-5-carbonitrile | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.